DEXRAZOXANE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Dexrazoxane Hydrochloride patents expire, and what generic alternatives are available?
Dexrazoxane Hydrochloride is a drug marketed by Eugia Pharma, Gland, and Hikma. and is included in three NDAs.
The generic ingredient in DEXRAZOXANE HYDROCHLORIDE is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexrazoxane Hydrochloride
A generic version of DEXRAZOXANE HYDROCHLORIDE was approved as dexrazoxane hydrochloride by HIKMA on September 28th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXRAZOXANE HYDROCHLORIDE?
- What are the global sales for DEXRAZOXANE HYDROCHLORIDE?
- What is Average Wholesale Price for DEXRAZOXANE HYDROCHLORIDE?
Summary for DEXRAZOXANE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Clinical Trials: | 58 |
| Patent Applications: | 393 |
| DailyMed Link: | DEXRAZOXANE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DEXRAZOXANE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ain Shams University | Phase 2/Phase 3 |
| Maria Sklodowska-Curie National Research Institute of Oncology | Phase 3 |
| Polish Medical Research Agency | Phase 3 |
Pharmacology for DEXRAZOXANE HYDROCHLORIDE
| Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for DEXRAZOXANE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DEXRAZOXANE HYDROCHLORIDE
US Patents and Regulatory Information for DEXRAZOXANE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 200752-001 | Oct 19, 2011 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 207321-001 | Nov 28, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 200752-002 | Oct 19, 2011 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
